Papers: 10.1371/journal.pgen.1006593

https://doi.org/10.1371/journal.pgen.1006593

Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer’s disease

Cited by: 99
Author(s): Fiona Kerr, Oyinkan Sofola-Adesakin, Dobril Ivanov, Jemma Gatliff, Beatriz Gomez Perez‐Nievas, Hélène Bertrand, Pedro Martı́nez, Rebecca Callard, Inge Snoeren, Helena M. Cochemé, Jennifer Adcott, Mobina Khericha, Jorge Iván Castillo-Quan, Geoff Wells, Wendy Noble, Janet M. Thornton, Linda Partridge
Published: over 8 years ago

Software Mentions 4